Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Climb Global Solutions
CLMB
$532M
| $5.29M | 0.01% |
1,094,400
+24,400
| +2% | +$120K |
|
1677
First Citizens BancShares
FCNCA
$25.9B
| $5.29M | 0.01% |
14,200
-10,800
| -43% | -$3.73M |
|
|
SIFI
1678
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
| $5.29M | 0.01% |
328,459
+23,150
| +8% | +$349K |
|
|
HNH
1679
DELISTED
Handy & Harman Holdings Ltd.
HNH
| $5.28M | 0.01% |
168,180
+8,400
| +5% | +$234K |
|
|
MYCC
1680
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $5.28M | 0.01% |
402,700
-173,400
| -30% | -$2.36M |
|
|
BLD
1681
DELISTED
TopBuild
BLD
| $5.25M | 0.01% |
+99,000
| New | +$5.07M |
|
|
GDEN
1682
DELISTED
Golden Entertainment
GDEN
| $5.23M | 0.01% |
252,650
-11,950
| -5% | -$197K |
|
1683
1st Source
SRCE
$2.13B
| $5.23M | 0.01% |
109,040
+13,600
| +14% | +$642K |
|
|
AVEO
1684
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $5.22M | 0.01% |
235,340
-35,100
| -13% | -$276K |
|
1685
OneSpan
OSPN
$602M
| $5.22M | 0.01% |
363,600
-63,300
| -15% | -$869K |
|
1686
Seres Therapeutics
MCRB
$45.6M
| $5.2M | 0.01% |
23,015
+5,475
| +31% | +$1.12M |
|
1687
Caesarstone
CSTE
$119M
| $5.2M | 0.01% |
+148,235
| New | +$5.56M |
|
1688
Genesco
GCO
$391M
| $5.19M | 0.01% |
+153,100
| New | +$6.84M |
|
|
MCRN
1689
DELISTED
Milacron Holdings Corp.
MCRN
| $5.17M | 0.01% |
294,000
+206,500
| +236% | +$3.7M |
|
|
TESS
1690
DELISTED
Tessco Technologies Inc
TESS
| $5.17M | 0.01% |
388,579
+15,831
| +4% | +$223K |
|
|
HSNI
1691
DELISTED
HSN, Inc.
HSNI
| $5.16M | 0.01% |
161,849
+57,271
| +55% | +$1.98M |
|
|
ENIA
1692
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $5.16M | 0.01% |
546,800
-258,700
| -32% | -$2.54M |
|
|
CCP
1693
DELISTED
Care Capital Properties, Inc.
CCP
| $5.16M | 0.01% |
+193,080
| New | +$5.21M |
|
1694
Canadian Natural Resources
CNQ
$98.9B
| $5.15M | 0.01% |
364,701
-619,951
| -63% | -$9.33M |
|
|
YRD
1695
Yiren Digital
YRD
$104M
| $5.15M | 0.01% |
206,000
+35,400
| +21% | +$859K |
|
|
NAME
1696
DELISTED
Rightside Group, Ltd.
NAME
| $5.15M | 0.01% |
484,705
-5,900
| -1% | -$58.1K |
|
|
COTV
1697
DELISTED
Cotiviti Holdings, Inc.
COTV
| $5.14M | 0.01% |
138,513
-179,987
| -57% | -$7.07M |
|
|
KNL
1698
DELISTED
Knoll, Inc.
KNL
| $5.14M | 0.01% |
256,298
+126,098
| +97% | +$2.84M |
|
|
IMGN
1699
DELISTED
Immunogen Inc
IMGN
| $5.14M | 0.01% |
722,340
-755,606
| -51% | -$3.46M |
|
|
MITL
1700
DELISTED
Mitel Networks Corporation
MITL
| $5.13M | 0.01% |
698,288
+68,600
| +11% | +$478K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.